Impact of Ketogenic Diets in Preventing Relapse in Obesity Management
Ketomaintain
Evaluation of the Efficacy, Feasibility, and Safety of Ketogenic Diets in Preventing Relapse in Obesity Management
1 other identifier
interventional
25
1 country
1
Brief Summary
Low-carb ketogenic diets have become extremely popular because of large weight loss in the short-term. Yet their potential benefits in preventing long-term weight regain have not been assessed in large scale studies. The aim of this study is to determine the effect of a low-carbohydrate (CHO) ketogenic diet, compared with an isocaloric balanced diet, on the maintenance of weight loss. The secondary aim is to investigate the impact of both diets on appetite. Adults with obesity (30\<BMI\<40 kg/m2), will first undergo 4 weeks of a very-low energy diet aimed at inducing 5-10% weight loss and then will be randomized to two different weight maintenance diets for 1 year. One will be a low-CHO ketogenic diet (50 g CHO/day) plant-based (e.g. with less animal protein and more plant-based), and the other a diet following the Norwegian Health Directorate recommendations. Only conventional foods will be used in both diets.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable obesity
Started Aug 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 28, 2020
CompletedFirst Posted
Study publicly available on registry
May 11, 2020
CompletedStudy Start
First participant enrolled
August 3, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 10, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 10, 2021
CompletedApril 29, 2022
April 1, 2022
1.4 years
April 28, 2020
April 28, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Body weight regain
Body weight will be measured at baseline, at week 5, at 6 months, and at 1 year
Body weight changes at 1-year intervention
Secondary Outcomes (2)
Fasting lipid profile
Lipid profile changes at 1-year intervention
Bone mineral density
Bone mineral density changes at 1-year intervention
Study Arms (2)
Ketogenic weight loss maintenance diet
EXPERIMENTALThe ketogenic weight loss maintenance group will undergo in a ketogenic diet (50 g CHO/day) plant-based for 1 year.
Isocaloric balanced weight loss maintenance diet
EXPERIMENTALThe isocaloric balanced weight loss maintenance group will undergo in a diet following the standard Norwegian Health Directorate recommendations for 1 year.
Interventions
The ketogenic weight loss maintenance group will undergo in a ketogenic diet (50 g CHO/day) plant-based for 1 year.
The isocaloric balanced weight loss maintenance group will undergo in a diet following the recommendations from the Norwegian Health Directorate for 1 year.
Eligibility Criteria
You may qualify if:
- weight stable over the last three months (\<2 kg)
- not currently dieting to lose weight
- inactive lifestyle (less than 150 min of physical activity weekly.
- Given that some of the variables of interest have been shown to be affected by the phase of menstrual cycle in normally ovulating women, namely appetite and resting metabolic rate, only women taking oral contraceptives, with regular menstrual cycles or post-menopausal will be included in the study
You may not qualify if:
- pregnancy
- breast-feeding
- drug or alcohol abuse within the last two years
- clinically significant illness including diabetes, gastrointestinal (particularly cholelithiasis), kidney (GFR \<60) or liver disease, osteoporosis (T-score \<-2.5) and osteopenia (T-score \<-1.5)
- treatment with antiosteoporotic drug
- depression or other psychological disorders
- eating disorders
- milk intolerance
- current medication known to affect appetite/metabolism or induce weight loss.
- a planned surgery during the study period
- participating in another research study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Norwegian University of Science and Technologylead
- St. Olavs Hospitalcollaborator
Study Sites (1)
Forsyningssenteret at NTNU
Trondheim, Norway
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Torstein Baade Rø, MD PhD
NTNU Faculty of Medicine and Health Sciences, IKOM
- STUDY DIRECTOR
Birger Henning Endreseth, Professor
St. Olvas Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 28, 2020
First Posted
May 11, 2020
Study Start
August 3, 2020
Primary Completion
December 10, 2021
Study Completion
December 10, 2021
Last Updated
April 29, 2022
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will not share